AGENT, USES AND METHODS FOR TREATMENT

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230159643A1
SERIAL NO

18057104

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level of progranulin (PGRN). In particular, these antibodies can be used in the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
H LUNDBECK A/S2500 VALBY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Biilmann, Rønn Lars Christian Valby, DK 6 27
Christensen, Soren Valby, DK 16 191
de, Jong Rob Utrecht, NL 20 56
Egebjerg, Jan Valby, DK 9 35
Gerritsen, Amout Utrecht, NL 1 0
Malik, Ibrahim John Valby, DK 19 173
Parren, Paul Utrecht, NL 234 3032
Stavenhagen, Jeffrey B Valby, DK 24 485
van, den Brink Edward Utrecht, NL 38 279

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation